308 related articles for article (PubMed ID: 26765516)
1. Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.
Chew SY; Than LT
Mycoses; 2016 May; 59(5):262-73. PubMed ID: 26765516
[TBL] [Abstract][Full Text] [Related]
2. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
3. Local treatment of vulvovaginal candidosis : general and practical considerations.
das Neves J; Pinto E; Teixeira B; Dias G; Rocha P; Cunha T; Santos B; Amaral MH; Bahia MF
Drugs; 2008; 68(13):1787-802. PubMed ID: 18729533
[TBL] [Abstract][Full Text] [Related]
4. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
Mendling W; Brasch J; ; ; ;
Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of vitamin B complex as an adjuvant therapy for the treatment of complicated vulvovaginal candidiasis: An in vivo and in vitro study.
Sun MG; Huang Y; Xu YH; Cao YX
Biomed Pharmacother; 2017 Apr; 88():770-777. PubMed ID: 28157653
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of acute and recurrent vulvovaginal candidiasis (VVC/rVVC)--state of art in 2008. Expert Board of Polish Gynecological Society].
Kotarski J; Drews K; Maleszka R; Rechberger T; Woroń J; Tomaszewski J;
Ginekol Pol; 2008 Sep; 79(9):638-52. PubMed ID: 18939517
[TBL] [Abstract][Full Text] [Related]
7. The Elusive Anti-
Tso GHW; Reales-Calderon JA; Pavelka N
Front Immunol; 2018; 9():897. PubMed ID: 29755472
[TBL] [Abstract][Full Text] [Related]
8. Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Farr A; Effendy I; Frey Tirri B; Hof H; Mayser P; Petricevic L; Ruhnke M; Schaller M; Schaefer APA; Sustr V; Willinger B; Mendling W
Mycoses; 2021 Jun; 64(6):583-602. PubMed ID: 33529414
[TBL] [Abstract][Full Text] [Related]
9. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol.
Lírio J; Giraldo PC; Amaral RL; Sarmento ACA; Costa APF; Gonçalves AK
BMJ Open; 2019 May; 9(5):e027489. PubMed ID: 31122991
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for vulvovaginal candidiasis, 1993.
Reef SE; Levine WC; McNeil MM; Fisher-Hoch S; Holmberg SD; Duerr A; Smith D; Sobel JD; Pinner RW
Clin Infect Dis; 1995 Apr; 20 Suppl 1():S80-90. PubMed ID: 7795112
[TBL] [Abstract][Full Text] [Related]
11. [Combined single-day treatment in acute vulvovaginal candidosis].
Kovachev S; Nacheva A; Vacheva-Dobrevska R; Vasilev N
Akush Ginekol (Sofiia); 2009; 48(6):18-23. PubMed ID: 20225492
[TBL] [Abstract][Full Text] [Related]
12. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
Fan SR; Liu XP
Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
14. [Genital candidiasis].
Ono F; Yasumoto S
Nihon Rinsho; 2009 Jan; 67(1):157-61. PubMed ID: 19177766
[TBL] [Abstract][Full Text] [Related]
15. Oral Ibrexafungerp: an investigational agent for the treatment of vulvovaginal candidiasis.
Azie N; Angulo D; Dehn B; Sobel JD
Expert Opin Investig Drugs; 2020 Sep; 29(9):893-900. PubMed ID: 32746636
[TBL] [Abstract][Full Text] [Related]
16. Vulvovaginal candidiasis: a comparison of HIV-positive and -negative women.
Sobel JD
Int J STD AIDS; 2002 Jun; 13(6):358-62. PubMed ID: 12015006
[TBL] [Abstract][Full Text] [Related]
17. Women's use of over-the-counter antifungal medications for gynecologic symptoms.
Ferris DG; Dekle C; Litaker MS
J Fam Pract; 1996 Jun; 42(6):595-600. PubMed ID: 8656170
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
Nagashima M; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
[TBL] [Abstract][Full Text] [Related]
19. Treatment of vulvovaginal candidiasis: a review of the literature.
Dovnik A; Golle A; Novak D; Arko D; Takač I
Acta Dermatovenerol Alp Pannonica Adriat; 2015; 24(1):5-7. PubMed ID: 25770305
[TBL] [Abstract][Full Text] [Related]
20. [The statement of Polish Gynecological Society Experts on the treatment of acute vulvovaginal candidiasis with prolonged releasing 2% butoconazole nitrate vaginal cream--state of art in 2008].
Expert Board of Polish Gynecological Society
Ginekol Pol; 2009 Apr; 80(4):303-11. PubMed ID: 19507567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
